2566 — Hangzhou Jiuyuan Genetic Biopharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapContrarian

Market Cap
HK$2.25bn
Enterprise Value
HK$1.61bn
Revenue
CNY1.31bn

Annual balance sheet for Hangzhou Jiuyuan Genetic Biopharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	128	116	126	611	714
Net Total Accounts Receivable
Net Total Receivables	409	460	526	639	605
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	748	759	840	1,410	1,483
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	405	389	377	355	426
Net Intangible Assets
Other Long Term Assets
Total Assets	1,183	1,214	1,308	1,923	2,118
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	401	356	348	342	332
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	465	447	410	405	470
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	718	766	898	1,518	1,648
Total Liabilities & Shareholders' Equity	1,183	1,214	1,308	1,923	2,118
Total Common Shares Outstanding